GeneDx Holdings Corp. (WGS)

US — Healthcare Sector
Peers: NHIQ  TALK  UTRS 

Automate Your Wheel Strategy on WGS

With Tiblio's Option Bot, you can configure your own wheel strategy including WGS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol WGS
  • Rev/Share 12.6776
  • Book/Share 9.6968
  • PB 10.9159
  • Debt/Equity 0.2263
  • CurrentRatio 2.8686
  • ROIC 0.0081

 

  • MktCap 3040668270.0
  • FreeCF/Share 0.2033
  • PFCF 523.3759
  • PE 2151.6086
  • Debt/Assets 0.1352
  • DivYield 0
  • ROE 0.0057

 

  • Rating C
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 1
  • D/E Score 2

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Initiation WGS Piper Sandler -- Overweight -- $110 July 9, 2025
Initiation WGS Guggenheim -- Buy -- $88 May 15, 2025
Upgrade WGS Jefferies Hold Buy -- $80 May 9, 2025
Initiation WGS Wells Fargo -- Equal Weight -- $34 Aug. 28, 2024

News

GeneDx Holdings Corp. (WGS) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates
WGS
Published: February 10, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of GeneDx Holdings Corp. ("GeneDx Holdings Corp.") (NASDAQ:WGS) concerning possible violations of federal securities laws. Grizzly Research ("Grizzly") published a report on February 5, 2025, entitled "Insiders Attest That GeneDx (Nasdaq: WGS) Is Actively Committing Widespread Fraud".

Read More
image for news GeneDx Holdings Corp. (WGS) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates
Levi & Korsinsky Reminds Shareholders of an Investigation into GeneDx Holdings Corp. (WGS) Regarding Potential Securities Fraud Allegations
WGS
Published: February 10, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of GeneDx Holdings Corp. ("GeneDx Holdings Corp.") (NASDAQ:WGS) concerning possible violations of federal securities laws. Grizzly Research ("Grizzly") published a report on February 5, 2025, entitled "Insiders Attest That GeneDx (Nasdaq: WGS) Is Actively Committing Widespread Fraud".

Read More
image for news Levi & Korsinsky Reminds Shareholders of an Investigation into GeneDx Holdings Corp. (WGS) Regarding Potential Securities Fraud Allegations
Bronstein, Gewirtz & Grossman, LLC Encourages GeneDx Holdings Corp. (WGS) Investors to Inquire about Securities Investigation
WGS
Published: February 10, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GeneDx Holdings Corp. ("GeneDx" or "the Company") (NASDAQ:WGS). Investors who purchased GeneDx securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/WGS.

Read More
image for news Bronstein, Gewirtz & Grossman, LLC Encourages GeneDx Holdings Corp. (WGS) Investors to Inquire about Securities Investigation

About GeneDx Holdings Corp. (WGS)

  • IPO Date 2020-11-04
  • Website http://www.genedx.com
  • Industry Medical - Healthcare Information Services
  • CEO Katherine A. Stueland
  • Employees 1000

GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.